Bumper Offer - Urjas oil Just @ Rs. 1
Ramihart 2.5 Mg Capsule, a prescription drug, is manufactured in various forms such as Capsule. It is primarily used for the treatment of High BP. The alternative uses of Ramihart 2.5 Mg Capsule have also been explained below.
The optimal dosage of Ramihart 2.5 Mg Capsule is largely dependent on the individual's body weight, medical history, gender and age. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
The most common side effects of Ramihart 2.5 Mg Capsule are Confusion. While these are the most often observed Ramihart 2.5 Mg Capsule side effects, there are can be others also. These have been listed below. Such side effects of Ramihart 2.5 Mg Capsule normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Ramihart 2.5 Mg Capsule's effect is Severe during pregnancy and Mild for lactating mothers. Further, the section on Ramihart 2.5 Mg Capsule related warnings talks about Ramihart 2.5 Mg Capsule's effects on the liver, heart and kidney.
Ramihart 2.5 Mg Capsule is not recommended if you suffer from certain medical conditions as it can have adverse effects. Angioedema, Heart Failure, Low Blood Pressure (Hypotension) are examples of such conditions. Some other conditions that can be affected by Ramihart 2.5 Mg Capsule are listed in the contraindications section below.
Drug reaction of Ramihart 2.5 Mg Capsule with other medicines has been reported. See below for a complete list.
You should also be aware that Ramihart 2.5 Mg Capsule is not safe while driving, and is not addiction.
Ramihart 2.5 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Ramihart 2.5 Mg Capsule is used -
Mild
Common
Is the use of Ramihart 2.5 Mg Capsule safe for pregnant women?
Ramihart has many dangerous side effects in pregnant women. If you are pregnant, do not consume Ramihart without medical advice.
Is the use of Ramihart 2.5 Mg Capsule safe during breastfeeding?
Ramihart has been seen to have minimal side effects on breastfeeding women.
What is the effect of Ramihart 2.5 Mg Capsule on the Kidneys?
Ramihart has very mild side effects on the kidneys.
What is the effect of Ramihart 2.5 Mg Capsule on the Liver?
Side effects of Ramihart rarely affect the liver.
What is the effect of Ramihart 2.5 Mg Capsule on the Heart?
Side effects of Ramihart rarely affect the heart.
Ramihart 2.5 Mg Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ramihart 2.5 Mg Capsule unless your doctor advises you to do so -
Is this Ramihart 2.5 Mg Capsule habit forming or addictive?
No, you will not get addicted to Ramihart 2.5 Mg Capsule.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Ramihart 2.5 Mg Capsule. So it is best to avoid driving.
Is it safe?
Ramihart 2.5 Mg Capsule is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Ramihart 2.5 Mg Capsule for mental disorders.
Interaction between Food and Ramihart 2.5 Mg Capsule
Eating certain foods may increase the time it takes Ramihart 2.5 Mg Capsule to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Ramihart 2.5 Mg Capsule
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Ramihart 2.5 Mg Capsule.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169